Riskpilot← Back to searchSign inGet full accessPSV GP Tech Fund I ApS
APSActiveCVR 41388730Diplomvej 381Activities of holding companies · NACE 6421Est. 2020— employees
Revenue 2024
DKK 30K
-474% vs 2023
EBITDA margin
100.0%
+474% vs 2023
Equity ratio
59.8%
Financial strength
Net profit 2024
DKK 27K
+432% vs 2023
| Revenue | DKK 30K | -474% |
| EBITDA | DKK 30K | +474% |
| Net profit | DKK 27K | +432% |
| Total assets | DKK 80K | +85% |
| Equity | DKK 48K | +124% |
| Employees | — | — |
Legal name
PSV GP Tech Fund I ApS
CVR number
41388730
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
26. maj 2020
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening eller af den samlede direktion.
Company purpose
Selskabets formål er at være komplementar i kommanditselskaber relateret til PreSeed Ventures.
Address
Diplomvej 381
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -5 | -1 | -1 | -8 | 30 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -5 | -1 | -1 | -8 | 30 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -5 | -1 | -1 | -8 | 30 |
| Net financials | 0 | -0 | -3 | 0 | -0 |
| Profit before tax | -5 | -2 | -4 | -8 | 30 |
| Tax | -0 | -0 | -0 | -0 | 3 |
| Net profit | -5 | -2 | -4 | -8 | 27 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 40 | 40 | 46 | 43 | 80 |
| Equity | 35 | 33 | 29 | 21 | 48 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 7 | 17 | 22 | 32 |
| Total debt | 5 | 7 | 17 | 22 | 32 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20202024
Equity ratio
59.8%
This company
38.2%
Market median
+57% vs market
20202024
Return on equity
55.4%
This company
18.4%
Market median
+201% vs market
20202024
Net profit margin
88.8%
This company
8.1%
Market median
+996% vs market
20202024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20202024
Debt / equity
0.67×
This company
0.62×
Market median
+8% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-05-26 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RB Management | Management | 2020 | — | — |
CA Management | Management | 2020 | — | — |
HL Management | Management | 2020 | — | — |
AK Management | Management | 2022 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Breiter Invest ApS | Company | 25.0% | 25.0% | 2020 |
Viterbo-Horten Holding ApS | Company | 25.0% | 25.0% | 2022 |
NOLIXA ApS | Company | 25.0% | 25.0% | 2020 |
MAREXA ApS | Company | 10.0% | 10.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MAREXA ApS
PSV GP Tech Fund I ApS Board members of PSV GP Tech Fund I ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Richard Breiter | Management | 0 companies |
| Christel Arpalice Piron | Management | 0 companies |
| Helle Lund Uth | Management | 0 companies |
| Alexander Korre Viterbo-Horten | Management | 0 companies |